Improve it trials
Witryna5 lis 2024 · The subsequent IMPROVE-ITtrial demonstrated that the addition of ezetimibe to statin therapy further reduces CV events in this population, suggesting that maximal LDL reduction is the key mechanism in improving outcomes in patients with established atherosclerotic disease. WitrynaThe risk of discontinuation was highest early in the trial but decreased with increasing time, with a terminal KM rate per 100 person-years of 8.4 (8.2-8.6) from years 1 to 7. Discontinuation was higher in the placebo+simvastatin versus ezetimibe+simvastatin arm (KM rate 52.0% versus 49.8%, P=0.049) and was highest in the United States (7-year ...
Improve it trials
Did you know?
WitrynaIMPROVE-IT TRIAL. - Hospitalized within the preceding 10 days for an acute coronary syndrome (an acute myocardial infarction, with or without ST-segment elevation on … Witryna1 dzień temu · The village trial will convert a large village of around 1,000-2,000 properties to hydrogen or alternative heating solution instead of natural gas. Led by …
Witryna2 godz. temu · Retail milk prices have risen the sharpest over the past decade in 2024-23, increasing by nearly 15%. The minister said demand for milk and milk products … Witryna9 mar 2016 · The IMPROVE-IT trial investigators adopted a novel and clinically relevant analytic approach to further understand ezetimibe's impact on clinical events. The analysis addresses the fact that patients with a nonfatal, first cardiovascular event are at risk of developing additional events. Due to the long duration of follow-up in …
Witryna1 dzień temu · The head of a review examining the reasons for a dramatic drop in clinical trials in the UK is urging the government to bring research out of overwhelmed … Witryna28 mar 2012 · IMPROVE-IT is an 18,000 patient event-driven trial, and based on the targeted number of clinical endpoints and the current rate at which events are being reported, the projected 2013 study completion date may change.
Witryna1 dzień temu · The village trial will convert a large village of around 1,000-2,000 properties to hydrogen or alternative heating solution instead of natural gas. Led by the gas distribution networks, it will ...
Witryna1 maj 2016 · Recent findings: IMPROVE-IT is the first trial that demonstrates a significant clinical benefit of a nonstatin hypolipidemic agent (ezetimibe) used in combination with statin (simvastatin) therapy ... fish restaurants florence scWitryna10 lis 2024 · Ongoing trials of moderate-to-high doses of pure EPA ethyl ester will provide further information on the effects of these agents. 10,36 These trials include the Randomized Trial for... fish restaurants fremantleWitryna10 gru 2014 · The IMPROVE-IT Trial The IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) is a randomized control study established to examine the clinical benefit and safety of Vytorin (ezetimibe/simvastatin) versus simvastatin alone in high-risk patients with post acute coronary syndrome. Additional … fish restaurants friscoWitrynaIMPROVE-IT is the first trial that demonstrates a significant clinical benefit of a nonstatin hypolipidemic agent (ezetimibe) used in combination with statin (simvastatin) therapy … candle light dinner in kopar khairaneWitryna21 lis 2014 · Nissen believes IMPROVE-IT is a positive trial, and despite flaws, it is a statistically valid result. He pointed out that the treatment effect was observed in a … candle light dinner in krabiWitrynaNational Center for Biotechnology Information fish restaurants franklin tnWitryna12 kwi 2015 · The IMPROVE-IT trial, launched 9 years ago, has finally provided physicians with long-term efficacy and safety evidence for ezetimibe. The large-scale study in acute-coronary-syndrome patients showed a clear benefit in reducing cardiovascular events when added to simvastatin in this population. fish restaurants fort worth tx